January 11th, 2016
Juno acquires Harvard spinout, AbVitro, for $125M to discover more cancer immunotherapies (Forbes)
Seattle-based Juno has agreed to acquire Boston-based AbVitro, a spinout from George Church’s lab at Harvard University.
News
Press Contact: Kirsten Mabry | (617) 495-4157
Featured Tags:
January 11th, 2016
Seattle-based Juno has agreed to acquire Boston-based AbVitro, a spinout from George Church’s lab at Harvard University.
January 8th, 2016
Ultra-compact polarimeter could improve telecommunications, medical diagnostics, and drug testing.
January 6th, 2016
For Harvard computer scientists, entrepreneurship is often a fulfilling extension of their cutting-edge research.
January 4th, 2016
Protein matrix vaccines, HDAC inhibitors, photocatalysis, supercharged proteins, and more.
December 23rd, 2015
UCB-funded Harvard study describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.